Mario Alberto Isiordia-Espinoza

Prof. Dr. Mario Alberto Isiordia-Espinoza

Centro Universitario de los Altos, Universidad de Guadalajara.
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MRMaría Leonor González Rivera
María Leonor González Rivera
Juan Carlos Barragan-GalvezJuan Carlos Barragan-Galvez
Juan Carlos Barragan-Galvez
DGDeisy Gasca-Martínez
Deisy Gasca-Martínez
SHSergio Hidalgo-Figueroa
Sergio Hidalgo-Figueroa
Mario Alberto Isiordia-EspinozaMario Alberto Isiordia-Espinoza
Mario Alberto Isiordia-Espinoza
Angel Josabad Alonso-CastroAngel Josabad Alonso-Castro
Angel Josabad Alonso-Castro
Neophytadiene (NPT) is a diterpene found in the methanolic extracts of Crataeva nurvala and Blumea lacera, plants reported with anxiolytic-like activity, sedative properties, and antidepressant-like actions; however, the contribution of neophytadiene to these effects is unknown. This study determined the neuropharmacological (anxiolytic-like, antidepressant-like, anticonvulsant, and sedative) effects of neophytadiene (0.1–10 mg/kg p.o.) and determined the mechanisms of action involved in the neuropharmacological actions using inhibitors such as flumazenil and analyzing the possible interaction of neophytadiene with GABA receptors using a molecular docking study. The behavioral tests were evaluated using the light–dark box, elevated plus-maze, open field, hole-board, convulsion, tail suspension, pentobarbital-induced sleeping, and rotarod. The results showed that neophytadiene exhibited anxiolytic-like activity only to the high dose (10 mg/kg) in the elevated plus-maze and hole-board tests, and anticonvulsant actions in the 4-aminopyridine and pentylenetetrazole-induced seizures test. The anxiolytic-like and anticonvulsant effects of neophytadiene were abolished with the pre-treatment with 2 mg/kg flumazenil. In addition, neophytadiene showed low antidepressant effects (about 3-fold lower) compared to fluoxetine. On other hand, neophytadiene had no sedative or locomotor effects. In conclusion, neophytadiene exerts anxiolytic-like and anticonvulsant activities with the probable participation of the GABAergic system.

1 February 2017 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Angel Josabad Alonso-CastroAngel Josabad Alonso-Castro
Angel Josabad Alonso-Castro
FDFabiola Domínguez
Fabiola Domínguez
JMJuan José Maldonado-Miranda
Juan José Maldonado-Miranda
Luis J. Castillo-PérezLuis J. Castillo-Pérez
Luis J. Castillo-Pérez
CCCandy Carranza-Álvarez
Candy Carranza-Álvarez
LOLuis Manuel Orozco-Castellanos
Luis Manuel Orozco-Castellanos

12 April 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Efigenia Montalvo-GonzálezEfigenia Montalvo-González
Efigenia Montalvo-González
Zuamí VillagránZuamí Villagrán
Zuamí Villagrán
YGYesica Sughey González-Torres
Yesica Sughey González-Torres
LILaura Elena Iñiguez-Muñoz
Laura Elena Iñiguez-Muñoz
Mario Alberto Isiordia-EspinozaMario Alberto Isiordia-Espinoza
Mario Alberto Isiordia-Espinoza
LALuis Anaya
Luis Anaya
Hibiscus sabdariffa Linn. Malvaceae (HS) is characterized by its edible calyxes. The HS calyxes are widely used for cosmetic, food, and medicinal applications. According to ethnobotanical evidence, decoction, infusion, or maceration extracts from HS calyxes have been used in folk medicine to treat many ailments. Moreover, several in vitro and in vivo studies have demonstrated the pharmacological properties and potential human health benefits of HS consumption. On the other hand, the evaluation of the physiological effects and health benefits of HS in clinical studies is most challenging. Therefore, this narrative review summarizes and discusses the physiological effects and health benefits of HS calyxes reported in clinical trials. Preparations obtained from HS calyxes (extracts, infusions, decoction, teas, beverages, capsules, and pills) are used as non-pharmacological therapies to prevent/control diverse chronic non-communicable diseases. The most-reported HS health benefits are its antihypertensive, antidyslipidemic, hypoglycemic, body fat mass reduction, nephroprotective, antianemic, antioxidant, anti-inflammatory, and anti-xerostomic activities; these effects are associated with the phytochemicals found in HS. Moreover, no adverse effects were reported during the clinical trials. However, clinical studies exhibited some limitations; thus, further studies are required to validate the clinical efficacy of HS in large-scale studies with higher doses and a good experimental design

20 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
VPVanesa Pereira-Prado
Vanesa Pereira-Prado
FMFelipe Martins-Silveira
Felipe Martins-Silveira
ESEstefanía Sicco
Estefanía Sicco
JHJimena Hochmann
Jimena Hochmann
Mario Alberto Isiordia-EspinozaMario Alberto Isiordia-Espinoza
Mario Alberto Isiordia-Espinoza
Ronell Bologna-MolinaRonell Bologna-Molina
Ronell Bologna-Molina
Head and neck tumor differential diagnosis and prognosis have always been a challenge for oral pathologists due to their similarities and complexity. Artificial intelligence novel applications can function as an auxiliary tool for the objective interpretation of histomorphological digital slides. In this review, we present digital histopathological image analysis applications in oral squamous cell carcinoma. A literature search was performed in PubMed MEDLINE with the following keywords: “artificial intelligence” OR “deep learning” OR “machine learning” AND “oral squamous cell carcinoma”. Artificial intelligence has proven to be a helpful tool in histopathological image analysis of tumors and other lesions, even though it is necessary to continue researching in this area, mainly for clinical validation.

1 January 2011 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Closed access
Mario Alberto Isiordia-EspinozaMario Alberto Isiordia-Espinoza
Mario Alberto Isiordia-Espinoza
Amaury Pozos-GuillénAmaury Pozos-Guillén
Amaury Pozos-Guillén
RMR. Martinez-Rider
R. Martinez-Rider
JHJe. Herrera-Abarca
Je. Herrera-Abarca
JPJ. Perez-Urizar
J. Perez-Urizar
The aim of this study was to compare preemptive analgesia of oral ketorolac plus submucous local placebo with oral ketorolac plus submucous local tramadol after impacted mandibular third molar surgery. A double-blind, randomized, placebo-controlled clinical trial was conducted. Patients were randomized into two treatment groups (n = 15 per group): group A, oral ketorolac 10 mg, 30 minutes before surgery plus submucous local placebo (1 mL saline solution); group B, oral ketorolac 10 mg, 30 minutes before surgery plus submucous local tramadol (50 mg diluted in 1 mL saline solution). We evaluated the intensity of pain, time for the first analgesic rescue medication, and total analgesic consumption. Pain intensity, number of patients requiring analgesic rescue medication, number of patients in each group not requiring analgesic rescue medication, and total analgesic consumption showed statistical significance. Preemptive use of oral ketorolac plus submucous local tramadol is an alternative treatment for acute pain after surgical removal of an impacted mandibular third molar.

1 January 2016 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
MOM Orozco-Solis
M Orozco-Solis
YGY Garcia-Avalos
Y Garcia-Avalos
CPC Pichardo-Ramirez
C Pichardo-Ramirez
FTF Tobias-Azua
F Tobias-Azua
JZJuan Ramón Zapata-Morales
Juan Ramón Zapata-Morales
Mario Alberto Isiordia-EspinozaMario Alberto Isiordia-Espinoza
Mario Alberto Isiordia-Espinoza
Postoperative pain associated with removal of mandibular third molars has been documented from moderate to severe during the first 24 hours after surgery, with pain peaking between 6 and 8 hours when a conventional local anesthetic is used. Dental pain is largely inflammatory, and evidence-based medicine has shown that nonsteroidal anti-inflammatory drugs are the best analgesics for dental pain. The aim of this study was to compare the analgesic, anti-inflammatory and anti-trismus effect of a single dose of diclofenac and meloxicam after mandibular third molar extraction. A total of 36 patients were randomized into two treatment groups, each with 18 patients, using a series of random numbers: Group A, was administered 100 mg of diclofenac; and Group B, 15 mg of meloxicam. Drugs were administered orally 1 hour prior to surgery. We evaluated pain intensity, analgesic consumption, swelling, as well as trismus. The results of this study showed that patients receiving 15 mg of meloxicam had less postoperative pain (P=0.04) and better aperture than those receiving 100 mg of diclofenac (P=0.03). The meloxicam group presented less swelling than diclofenac group; however, significant statistical differences were not observed. Data of this double-blind, randomized, parallel-group clinical trial demonstrated that patients receiving 15 mg of preoperative meloxicam had a better postoperative analgesia and anti-trismus effect compared with who were given 100 mg of diclofenac after third molar extractions. Key words:Diclofenac, meloxicam, dental pain, trismus, third molar surgery.